Similarly, the combination of suboptimal concentration of isoliquiritigenin and TRAIL drastically enhanced apoptosis in colon cancer HT-29 cells compared with the single treatment of isoliquiritigenin. This evidence concerns the gene TNFSF10 and malignant colon neoplasm.